Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-18

FDA Approved: ZITUVIMET XR — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved ZITUVIMET XR (sitagliptin and metformin hydrochloride) as an extended-release fixed-dose combination for adults with type 2 diabetes mellitus to im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZITUVIMET XR (sitagliptin and metformin hydrochloride)

Snippet

ORIG AP for ZITUVIMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE)